BioLife Solutions
BLFS
73 hedge funds and large institutions have $150M invested in BioLife Solutions in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 9 closing their positions.
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
11% more funds holding
Funds holding: 66 → 73 (+7)
1.66% more ownership
Funds ownership: 46.11% → 47.77% (+1.7%)
10% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 21
2% less capital invested
Capital invested by funds: $154M → $150M (-$3.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$5.64M |
| 2 |
BlackRock
New York
|
+$5.32M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
+$3.64M |
| 4 |
RA
Royce & Associates
New York
|
+$3.25M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$3.3M |
| 2 |
SCM
Sandler Capital Management
New York
|
-$1.75M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.64M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.58M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$1.52M |
BLFS Hedge Fund Activity: Q2 2019 in Review
73 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q2 2019, worth a combined $150M — down 2.2% from $154M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new BLFS positions and 9 closed out — a net gain of 7 holders — while 23 added to existing stakes and 21 trimmed.
The largest buyer was Park West Asset Management, adding an estimated $5.64M. The largest seller was Renaissance Technologies, cutting an estimated $3.3M.
- 73 institutional investors held BioLife Solutions (BLFS) as of Q2 2019, up from 66 in Q1 2019.
- Funds reported $150M of BioLife Solutions stock for Q2 2019, down 2.2% quarter-over-quarter.
- 16 funds opened new BioLife Solutions positions in Q2 2019 and 9 closed out, a net change of +7 holders.
- The largest BioLife Solutions buyer in Q2 2019 was Park West Asset Management, an estimated $5.64M added.
- The largest BioLife Solutions seller in Q2 2019 was Renaissance Technologies, an estimated $3.3M sold.
Based on aggregated 13F filings for Q2 2019.